Rehmann Capital Advisory Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.44M | Buy |
40,251
+2,051
| +5% | +$120K | 0.13% | 123 |
|
|
2025
Q4 | $2.06M | Sell |
38,200
-1,070
| -3% | -$51.5K | 0.11% | 139 |
|
|
2025
Q3 | $1.77M | Buy |
39,270
+2,570
| +7% | +$120K | 0.1% | 148 |
|
|
2025
Q2 | $1.7M | Buy |
36,700
+2,372
| +7% | +$116K | 0.1% | 141 |
|
|
2025
Q1 | $2.09M | Buy |
34,328
+3,825
| +13% | +$223K | 0.13% | 119 |
|
|
2024
Q4 | $1.73M | Buy |
30,503
+2,933
| +11% | +$164K | 0.11% | 143 |
|
|
2024
Q3 | $1.43M | Buy |
27,570
+2,412
| +10% | +$113K | 0.09% | 161 |
|
|
2024
Q2 | $1.04M | Sell |
25,158
-1,449
| -5% | -$64.8K | 0.07% | 197 |
|
|
2024
Q1 | $1.44M | Buy |
26,607
+3,080
| +13% | +$157K | 0.11% | 150 |
|
|
2023
Q4 | $1.21M | Buy |
23,527
+46
| +0.2% | +$2.42K | 0.1% | 160 |
|
|
2023
Q3 | $1.36M | Sell |
23,481
-245
| -1% | -$15K | 0.13% | 129 |
|
|
2023
Q2 | $1.52M | Buy |
23,726
+1,403
| +6% | +$94.1K | 0.14% | 122 |
|
|
2023
Q1 | $1.55M | Buy |
22,323
+2,483
| +13% | +$175K | 0.15% | 123 |
|
|
2022
Q4 | $1.43M | Buy |
19,840
+919
| +5% | +$69.3K | 0.15% | 129 |
|
|
2022
Q3 | $1.35M | Buy |
18,921
+1,852
| +11% | +$134K | 0.15% | 129 |
|
|
2022
Q2 | $1.31M | Sell |
17,069
-341
| -2% | -$26K | 0.14% | 129 |
|
|
2022
Q1 | $1.27M | Buy |
17,410
+1,415
| +9% | +$95K | 0.12% | 147 |
|
|
2021
Q4 | $984K | Buy |
15,995
+304
| +2% | +$17.8K | 0.09% | 193 |
|
|
2021
Q3 | $928K | Sell |
15,691
-384
| -2% | -$25.3K | 0.09% | 200 |
|
|
2021
Q2 | $1.07M | Sell |
16,075
-3,291
| -17% | -$215K | 0.1% | 167 |
|
|
2021
Q1 | $1.22M | Buy |
19,366
+375
| +2% | +$23.3K | 0.13% | 139 |
|
|
2020
Q4 | $1.18M | Sell |
18,991
-1,073
| -5% | -$66K | 0.13% | 127 |
|
|
2020
Q3 | $1.21M | Buy |
20,064
+65
| +0.3% | +$3.91K | 0.15% | 120 |
|
|
2020
Q2 | $1.18M | Buy |
19,999
+2,767
| +16% | +$166K | 0.16% | 116 |
|
|
2020
Q1 | $961K | Buy |
+17,232
| New | +$1.05M | 0.16% | 113 |
|
|
2019
Q3 | – | Sell |
-10,209
| Closed | -$463K | – | 1719 |
|
|
2019
Q2 | $463K | Buy |
10,209
+224
| +2% | +$10.4K | 0.06% | 264 |
|
|
2019
Q1 | $476K | Sell |
9,985
-609
| -6% | -$30.3K | 0.06% | 231 |
|
|
2018
Q4 | $551K | Buy |
10,594
+32
| +0.3% | +$1.72K | 0.08% | 128 |
|
|
2018
Q3 | $656K | Sell |
10,562
-1,537
| -13% | -$91.2K | 0.09% | 177 |
|
|
2018
Q2 | $670K | Sell |
12,099
-754
| -6% | -$40.7K | 0.1% | 172 |
|
|
2018
Q1 | $813K | Sell |
12,853
-3,244
| -20% | -$209K | 0.13% | 133 |
|
|
2017
Q4 | $986K | Sell |
16,097
-134
| -0.8% | -$8.38K | 0.17% | 115 |
|
|
2017
Q3 | $1.03M | Buy |
16,231
+2,636
| +19% | +$154K | 0.19% | 107 |
|
|
2017
Q2 | $758K | Sell |
13,595
-1,917
| -12% | -$104K | 0.14% | 125 |
|
|
2017
Q1 | $844K | Buy |
15,512
+750
| +5% | +$41.1K | 0.14% | 132 |
|
|
2016
Q4 | $863K | Sell |
14,762
-442
| -3% | -$24.2K | 0.16% | 127 |
|
|
2016
Q3 | $820K | Sell |
15,204
-1,327
| -8% | -$85.2K | 0.16% | 118 |
|
|
2016
Q2 | $1.22M | Buy |
16,531
+3,365
| +26% | +$238K | 0.23% | 91 |
|
|
2016
Q1 | $841K | Buy |
13,166
+3,270
| +33% | +$206K | 0.16% | 111 |
|
|
2015
Q4 | $681K | Buy |
9,896
+480
| +5% | +$31.7K | 0.14% | 121 |
|
|
2015
Q3 | $557K | Sell |
9,416
-306
| -3% | -$19.4K | 0.13% | 133 |
|
|
2015
Q2 | $647K | Sell |
9,722
-322
| -3% | -$21.2K | 0.15% | 128 |
|
|
2015
Q1 | $648K | Sell |
10,044
-163
| -2% | -$10.2K | 0.15% | 131 |
|
|
2014
Q4 | $603K | Buy |
10,207
+462
| +5% | +$26.1K | 0.14% | 134 |
|
|
2014
Q3 | $499K | Buy |
9,745
+9
| +0.1% | +$450 | 0.12% | 147 |
|
|
2014
Q2 | $472K | Buy |
9,736
+1,936
| +25% | +$95.4K | 0.11% | 152 |
|
|
2014
Q1 | $405K | Sell |
7,800
-455
| -6% | -$24.2K | 0.11% | 161 |
|
|
2013
Q4 | $439K | Buy |
8,255
+795
| +11% | +$40.5K | 0.13% | 150 |
|
|
2013
Q3 | $345K | Buy |
7,460
+384
| +5% | +$16.9K | 0.11% | 170 |
|
|
2013
Q2 | $316K | Buy |
+7,076
| New | +$307K | 0.11% | 167 |
|
Other funds holding BMY
VCM
VPM
Rehmann Capital Advisory Group's BMY Position: Q1 2026 in Review
Rehmann Capital Advisory Group increased its Bristol-Myers Squibb (BMY) stake by 5.4% in Q1 2026, buying an estimated $120K and bringing the position to 40,251 shares worth $2.44M. The position accounts for 0.13% of the portfolio, ranked #123.
Rehmann Capital Advisory Group first reported a position in BMY in Q2 2013 and has held it in 50 quarters since. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Rehmann Capital Advisory Group held 40,251 shares of Bristol-Myers Squibb worth $2.44M as of Q1 2026.
- Rehmann Capital Advisory Group bought 2,051 Bristol-Myers Squibb shares in Q1 2026, an estimated $120K.
- Bristol-Myers Squibb made up 0.13% of Rehmann Capital Advisory Group's portfolio in Q1 2026, its #123 holding.
- Rehmann Capital Advisory Group first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 50 quarters since.
- 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Rehmann Capital Advisory Group's 13F filing for Q1 2026, filed 15 May 2026.